This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Series F financing brings £25mm to Oxford Nanopore Technologies
Oxford Nanopore Technologies Ltd. (formerly Oxford NanoLabs; single-molecule DNA sequencing and protein analysis) has raised £25mm ($41mm) in what is assumed to be its Series F round. Returning and first-time institutional and individual investors based in the UK and US participated, including Lansdowne Partners, seed backer IP Group, Invesco Perpetual, Redmile Group, and the company’s strategic partner Illumina. Taking into account the new financing, Oxford has accumulated £74mm to date.
Nanotechnology, Chips, etc.
Research, Analytical Equipment & Supplies
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?